The Journal Of Urology – Finessing Prostate Cancer Risk, Best Cystectomy Approach, and Reducing Low-Grade Bladder Cancer Recurrence (2025) Khene

Description

An analysis of key research in urological oncology, discussing the use of Bacillus Calmette-Guerin vs Gemcitabine for low-grade intermediate-risk bladder cancer, lessons learned from the randomized RAZOR trial comparing robot-assisted and open radical cystectomy, and redefining prostate cancer risk assessment based on the volume of Pattern 4 disease.